Literature DB >> 9894732

Pathophysiology of delirium.

R C van der Mast1.   

Abstract

Hypotheses about the pathophysiology of delirium are speculative and largely based on animal research. According to the neurotransmitter hypothesis, decreased oxidative metabolism in the brain causes cerebral dysfunction due to abnormalities of various neurotransmitter systems. Reduced cholinergic function, excess release of dopamine, norepinephrine, and glutamate, and both decreased and increased serotonergic and gamma-aminobutyric acid activity may underlie the different symptoms and clinical presentations of delirium. According to the inflammatory hypothesis, increased cerebral secretion of cytokines due to a wide range of physically stressful events plays an important role in the occurrence of delirium. Since cytokines can influence the activity of various neurotransmitter systems, these mechanisms may interact. Also, more fundamental processes like intraneuronal signal transduction, second messenger systems that at the same time use neurotransmitters as first messengers and play an important role in their synthesis and release, may be disturbed. Furthermore, severe illness and physiologic stress may give rise to modification of blood-brain barrier permeability, the sick euthyroid syndrome with abnormalities of thyroid hormone concentrations, and increased activity of the hypothalamic-pituitary-adrenal axis. These circumstances possibly also contribute to changes in neurotransmitter synthesis and release of cytokines in the brain, and consequently to the occurrence of delirium. Elderly patients are more at risk for developing delirium,very likely due to age-related cerebral changes in stress-regulating neurotransmitter and intracellular signal transduction systems. This paper will expand upon these current theories and discuss their applicability to research and clinical work with elderly patients suffering from delirium.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9894732     DOI: 10.1177/089198879801100304

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  36 in total

Review 1.  Delirium: an important (but often unrecognized) clinical syndrome.

Authors:  Terry Rabinowitz
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

Review 2.  Clinical pharmacology of old age syndromes.

Authors:  C Broadhurst; K C M Wilson; M T Kinirons; A Wagg; J K Dhesi
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

3.  Prevalence and risk factors for development of delirium in burn intensive care unit patients.

Authors:  Vivek Agarwal; Patrick J O'Neill; Bryan A Cotton; Brenda T Pun; Starre Haney; Jennifer Thompson; Nicholas Kassebaum; Ayumi Shintani; Jeffrey Guy; E Wesley Ely; Pratik Pandharipande
Journal:  J Burn Care Res       Date:  2010 Sep-Oct       Impact factor: 1.845

Review 4.  Incidence and associated factors of delirium after orthopedic surgery in elderly patients: a systematic review and meta-analysis.

Authors:  Yanjiang Yang; Xin Zhao; Lei Gao; Ying Wang; Juan Wang
Journal:  Aging Clin Exp Res       Date:  2020-08-09       Impact factor: 3.636

5.  The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness*.

Authors:  Jessica R Adams Wilson; Alessandro Morandi; Timothy D Girard; Jennifer L Thompson; Chad S Boomershine; Ayumi K Shintani; E Wesley Ely; Pratik P Pandharipande
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

6.  Changes in brain size with treatment in patients with hyper- or hypothyroidism.

Authors:  Angela Oatridge; Maria L Barnard; Basant K Puri; Simon D Taylor-Robinson; Joseph V Hajnal; Nadeem Saeed; Graeme M Bydder
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

7.  Off-Label Use of Dexmedetomidine for the Treatment of Delirium in the Intensive Care Unit.

Authors:  Huan Mark Nguyen; Doreen Pon
Journal:  P T       Date:  2016-10

Review 8.  The pharmacologic management of delirium in children and adolescents.

Authors:  Susan Beckwitt Turkel; Alan Hanft
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

9.  Thiamine deficiency and delirium.

Authors:  Kenneth Osiezagha; Shahid Ali; C Freeman; Narviar C Barker; Shagufta Jabeen; Sarbani Maitra; Yetunde Olagbemiro; William Richie; Rahn K Bailey
Journal:  Innov Clin Neurosci       Date:  2013-04

10.  Quetiapine Sustained Release in Treatment of Delirium Induced by Cerebral Metastasis.

Authors:  Antonino Messina; Anna Maria Fogliani
Journal:  Case Rep Oncol       Date:  2010-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.